Your session is about to expire
← Back to Search
Study Summary
This trial is studying how well DHA-paclitaxel works in treating patients with metastatic colorectal cancer.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Find a Location
Who is running the clinical trial?
Media Library
- I've had only one chemotherapy for my metastatic disease and it wasn't a taxane. It's been over 28 days since my last chemotherapy.I am not currently on any hormone treatments.It's been over 28 days since my last major radiotherapy, and I've recovered.It's been over 2 weeks since my last major surgery and I've recovered.My cancer in the colon or rectum has been confirmed by lab tests.My liver function tests are within the required limits.I am 18 years old or older.My kidney function, measured by creatinine, is within normal limits.My cancer has spread to other parts of my body.My heart rhythm is normal, and I haven't had a heart attack in the last 3 months.I do not have any serious health conditions that are not under control.I don't have severe nerve damage, uncontrolled seizures, or spinal cord compression.I do not have a serious infection needing IV treatment.I have had skin cancer or cervical cancer treated without recurrence, or any cancer treated surgically without recurrence for over 5 years.I do not have cancer that has spread to my brain.I have tried one chemotherapy treatment for my advanced cancer without success.I am fully active or can carry out light work.I am not currently on any immunotherapy treatments.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What are the deleterious effects of this medication?
"While there is some evidence to support the safety of this medication, it is only in Phase 2 trials. This means that there are no studies supporting its efficacy."
Are there still opportunities to join this research project?
"According to updated information on clinicaltrials.gov, this study is no longer recruiting patients for participation. Although the trial's last update was in 2008, there are over a thousand other trials currently enrolling individuals."
How many hospitals are currently participating in this trial?
"Presently, this trial is being conducted in 6 different locations. Some of these include Chicago, Baltimore and Lexington. To limit travel as much as possible, patients are encouraged to select the site that is closest to them."
Share this study with friends
Copy Link
Messenger